Immunotherapy directly into fluid cavities shows promise for pancreatic cancer
Disease control
Not yet recruiting
This study tests whether putting an immunotherapy drug (adebrelimab) directly into the chest or belly fluid can help control cancer-related fluid buildup in people with advanced pancreatic cancer. About 20 adults will receive the drug plus standard care. The goal is to see if thi…
Phase: PHASE2 • Sponsor: Sizhen Wang • Aim: Disease control
Last updated May 17, 2026 04:14 UTC